PreprintAll rights reservedbioRxiv
Liposomal DAGLβ Inhibitor Shows Substantial Antinociceptive Potency Mediated by AMPK in a Neuropathic Pain Mouse Models
- 1Virginia Commonwealth University
Related
- Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis
- 993 Optimizing management of immune checkpoint inhibitor-mediated toxicity in cancer patients
- Targeting SLC1A5-mediated glutamine metabolism overcomes PARP inhibitor resistance in ovarian cancer.
- First-line fecal microbiota transplantation for the management of immune checkpoint inhibitor-mediated diarrhea and colitis
- Plasmid-Mediated AmpC Detection in Escherichia coli and Klebsiella pneumoniae: In Vitro Prevalence and In Silico Inhibitor Design.
BibTeX
@misc{babcock2026liposomal,
title = {{Liposomal DAGLβ Inhibitor Shows Substantial Antinociceptive Potency Mediated by AMPK in a Neuropathic Pain Mouse Models}},
author = {L. A. Babcock and M. Gunawardena and P. E. Lowrey and R. Pangeni and M. Hall and M. Taylor and S. Chethan and S. M. Herz and D. A. Adeso and O. L. Murtagh and Q. Xu and K.-L. Hsu and A. H. Lichtman},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.15.758837},
url = {https://www.biorxiv.org/content/10.64898/2026.10.15.758837v1},
}
RIS
TY - UNPB
TI - Liposomal DAGLβ Inhibitor Shows Substantial Antinociceptive Potency Mediated by AMPK in a Neuropathic Pain Mouse Models
AU - L. A. Babcock
AU - M. Gunawardena
AU - P. E. Lowrey
AU - R. Pangeni
AU - M. Hall
AU - M. Taylor
AU - S. Chethan
AU - S. M. Herz
AU - D. A. Adeso
AU - O. L. Murtagh
AU - Q. Xu
AU - K.-L. Hsu
AU - A. H. Lichtman
PY - 2026
DA - 2026/10/15
PB - bioRxiv
DO - 10.64898/2026.10.15.758837
UR - https://www.biorxiv.org/content/10.64898/2026.10.15.758837v1
SN - 2692-8205
ER -